Publications

Peer Reviewed Journals

• Bhatt V, Nahata MC. Pharmacotherapy of patent ductus arteriosus.  Clin Pharm. 1989; 8:17-33.
• Bhatt V, Nahata MC.  Determination of exogenously administered dopamine in plasma using high performance liquid chromatography with electrochemical detection. J of Liq Chromatogra.1989; 12:1463-71. 
• Bhatt-Mehta V, Nahata, MC.  Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 1989; 9:303-14.
• Bhatt-Mehta V, Nahata MC.  The in-vitro stability of dopamine and theophylline, tolazoline, and dobutamine. J Perinatol. 1990; 10:129-133.
• Bhatt-Mehta V, Johnson C E, Schumacher R E, Pharmacokinetics of Gentamicin in neonates on extracorporeal membrane oxygenation. Clin Res 1990;38:897A.
• Bhatt-Mehta V, Nahata MC, McClead RE, Menke JA.  Clinical pharmacokinetics of dopamine in newborn infants. Eur J Clin Pharmacol 1991:40:593-97.
• Bhatt-Mehta V, Rosen D. Acute Pain Management in the Pediatric Patient.  Clin Pharm 1991; 10:667-85.
• Bhatt-Mehta V, Johnson C E, Schumacher R E. Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation. Pharmacotherapy 1992; 12:28-32.
• Bhatt-Mehta V, Schumacher RE. Criteria for use of synthetic surfactant (Exosurf NeonatalR) in newborn infants.   Clin Pharm 1992;11:355-57.
• Rosen DA, Bhatt-Mehta V, Rosen KR, Lomann A.  Oral sedation of infants and children in the ICU: A pharmacokinetic and pharmacodynamic study.  Anesth Analg 1992; 74:S256.
• Bhatt-Mehta V, Rosen DA, King R, Maksym C. Physical compatibility and chemical stability of midazolam hydrochloride in parenteral nutrition solutions.  Am J Hosp Pharm 1993;50:285-288.
• Bhatt-Mehta V, Johnson CJ, Kostoff L, Rosen DA. Stability of Extemporaneously prepared midazolam hydrochloride in flavored gelatin. Am J Hosp Pharm 1993; 50:472-475.
• Bhatt-Mehta V, Deluga K.  Fetal exposure to angiotensin-converting enzyme inhibitor Lisinopril-Neonatal manifestations and management.  Pharmacotherapy 1993; 13:515-518.
• Klarr JM, Faix RG, Pryce CJE, Bhatt-Mehta V.  A randomized, blinded, trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome.  J Pediatr1994:124:117-122.
• Klarr JM, Bhatt-Mehta V, Donn SM.  Neonatal adrenergic blockade following single dose maternal labetalol administration.  Am J Perinatol.  1994; 11:91-93.
• Johnson CE, Bhatt-Mehta V, Mancari S, McKown J.  Stability and Compatibility of Morphine Sulphate and Midazolam Hydrochloride during intravenous co-administration.  Am J Hosp Pharm.  1994;51:2812-15.
• Bhatt-Mehta V, Paglia R, Rosen DA.  Stability of Propofol with parenteral nutrient solutions during simulated y-site injection.  Am J Health-Syst Pharm.  1995:52; 192-96.
• Bhatt-Mehta V, Johnson CE, Donn SM, Thiesen V.  Accuracy and reliability of dosing equations to individualize Theophylline treatment in apnea of prematurity.  Pharmacotherapy.  1995; 15:246-50.
• Bhatt -Mehta V, Johnson CE, Leninger N, Agarwal M.  Stability and Compatibility of Fentanyl Citrate and Midazolam Hydrochloride During intravenous co-administration.  Am J Health-Syst Pharm.  1995; 52:511-13.
• Bhatt-Mehta V, Donn SM, Schork AM, Reed S, Johnson CE.  Prospective evaluation of two dosing equations for theophylline in premature infants.  Pharmacotherapy.  1996; 16:769-776.
• Bhatt-Mehta V.  Current guidelines for the treatment of acute pain in children.  Drugs. 1996;51:760-776.
• Nelson M, Schumacher RE, Nicks JJ, Becker MA,  Vrlenich LA, Bhatt-Mehta V, Schumacher RE .  Comparison of two methods of surfactant administration and the effect on dosing associated hypoxemia.  J Perinatol.  1997; 17: 450-454.
• Bhatt-Mehta V, Michaels, A, Hirata S.  Stability and compatibility of Atracurium besylate and Midazolam Hydrochloride during y-site co-infusion. Intn’l J Pharm Comp1998; 2:79-82.
• Bhatt-Mehta V, Rosen R.  Sedation in Children: Current Concepts. Pharmacotherapy. 1998; 18:790-807.
• Bhatt-Mehta, V, Schumacher RE, Faix G, Leady M, Brenner T.  Vancomycin Nephrotoxicity in Newborn infants.  Pediatrics1999; 103:1-4e.
• Rorstad A, Bhatt-Mehta, V.  Outpatient management of Asthma in children.  Pharmacy Times. 2000; May: 55-66.
• Fiore, T, Chapman R, Bhatt-Mehta V, Pearlman, M, Faix, R.  Maternal and    Transplacental Pharmacokinetics of Cefazolin for Intrapartum Prophylaxis of Group B Streptococcal In fection in Penicillin-allergic women.  Obstetrics and Gynecology 2001; 98:1075-1079.
• Odetola F, Bhatt-Mehta V, Moler F, Zahrra J, Custer J.  Pharmacokinetics of Cisatracurium in infants 0-2 years in a pediatric intensive care unit: An open label study. Pediatr Critic Care .2002; 3:250-54.
• Streetman DA, Bhatt-Mehta, V, Johnson CJ.  Treatment of acute asthma in children.  Ann Pharmacotherapy2002; 36:1249-1260.
• Bhatt-Mehta V, Schumacher RE. Treatment of Apnea of Prematurity (Invited review). Paediatr Drug2003; 5:195-210.
• Bhatt-Mehta V, Donn SM.  Gentamicin pharmacokinetics in neonates receiving high frequency oscillatory ventilation and conventional mechanical ventilation. J Perinatol2003; 23:559-62.
• Sadowski R, Dechert RE, Bandy KP,  Juno J, Bhatt-Mehta V, Custer JR, Moler FW, Bratton SL.  Continuous Quality Improvement: Reducing Unplanned Extubations in a Pediatric Intensive Care Unit. Pediatrics 2004; 114:628-632.
• Bhatt-Mehta, V, Donn SM. Letter to editor. Gentamicin pharmacokinetics in neonates receiving high frequency oscillatory ventilation and conventional mechanical ventilation. J Perinatol. 2004: 24, 266 – 267.
• Bhatt-Mehta V, Annich G.  Drug clearance during ECMO- Morphine and Lorazepam.  Perfusion. 2005; 20:309-15.
  Calhoun D, Ludtke S, Murthy NS, Bryant BG, Bhatt-Mehta, V. Recent advances in neonatology. Ann Pharmacotherapy. 2006;40:710-19.
• Baker CW, Barks JDE, Engmann C, Vazquez DM, Neal CR Jr,  Schumacher RE, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension. J Perinatol 2008; 28, 412-419.
• VanLooy JW, Schumacher RE, Bhatt-Mehta, V. Efficacy of a Premedication Algorithm for Nonemergent intubation in a neonatal Intensive Care Unit. Ann Pharmacother 2008, 42:947-55.
• Lattimore KA, Vazquez DM, Barks JD, Bhatt-Mehta, V. Developmental outcomes of very low birth weight infants treated with hydrocortisone for refractory hypotension. J Neonatal-Perinatal Medicine 2008; 1:225-232.
• Attar, Mohammad A, Bhatt-Mehta, V, Hieber S,  Schumacher R E. Can Prophylactic PDA Treatment Decrease Utilization of Hospital Resources? J of Neonatal-Perinatal Medicine 2009; 2:175-179.
• Bhatt-Mehta, V,  Barks JD. Free vs total cortisol in the treatment of relative adrenal insufficiency of the newborn. Journal of Neonatal-Perinatal Medicine  2011;4:247-252.
• Smith PB, Cohen-Wolkowiez, M, Castro, L,  Poindexter, B, Bidegain M, Weitkamp JH,   Schelonka, LR, Ward, RM,  Wade, K, Valencia, G, Burchfield, D, Arrieta, A, Bhatt-Mehta, V, Walsh, M,  Kantak, A, Rasmussen, M, Sullivan, JE, Finer, N, Brozanski, BS, Sanchez, P, van den Anker, J, Blumer, J, Kearns, G,  Capparelli, EV, Anand, R,  Benjamin Jr. DK on behalf of the Meropenem Study Team.
• Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid in Infants with Suspected or Complicated Intra-abdominal Infections. Pediatr Infect Dis J 2011;30:844-849.
• Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Bhatt-Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK Jr, Smith PB; for the Meropenem Study Team.
• Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections. Clin Infect Dis. 2012 Dec; 55:1495-1502.
• Shellhas R, Ng, C, Dillon C, Barks J, Ng, C, Bhatt-Mehta, V. Population Pharmacokinetics of Phenobarbital in Infants with Neonatal Encephalopathy treated with Therapeutic Hypothermia. Pediatr Crit Care Med 2013; 14:194–202.
• Attar MA, Vasileff AS, Schumacher RE, Wojtecki JA, Bhatt-Mehta V. Outcome of Two Prophylactic Treatment Choices for Patent Ductus Arteriosus in a Neonatal Intensive Care Unit. Asian J Med Res. 2013; 2: 54-57.
• Bhatt-Mehta V, Ng CM, Schumacher RE. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in-utero drug exposure to substances of abuse. Pediatr Crit Care Med 2014; 15:162–169
• Vezina HE, Ng CM, Vazquez DM, Barks JD, Bhatt-Mehta, V. Population Pharmacokinetics of Unbound Hydrocortisone in Critically Ill Neonates and Infants With Vasopressor-Resistant  Hypotension.  Pediatr Crit Care Med 2014;15: 546-53.
• Sarkar SS, Bhatt-Mehta V, Sarkar S. Does Maternal Intrapartum Antibiotic Treatment Prolong the Incubation Time Required for Blood Cultures to Become Positive for Infants with Early-Onset Sepsis? Am J Perinatol  2014 Sep 13. [Epub ahead of print]

In Preparation

• Bhatt-Mehta, V et al. Surfactant prophylaxis and BPD . (In preparation)
• Israel E, Bhatt-Mehta, V. Use of hydrocortisone in neonates (in preparation)

Non-peer Reviewed Journals/Manuals/Books

• Rosen DA, Rosen KR, Bhatt-Mehta V.  Options for continuous sedation in the pediatric intensive care unit.   Excerpta Medica. June, 1991.
• Bhatt-Mehta, V, Donn SM.
  Neonatal Pharmacokinetics.  In:  Donn SM(ed): The Michigan Manual of Guide to Neonatal Intensive Care. Futura Publishing Co.,Mt Kisco, NY, 1996, 2003.

• Bhatt-Mehta, V
  Drugs in Breastfeeding.  In:  Donn SM (ed).  The Michigan Manual of Guide to Neonatal Intensive Care.  Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

• Bhatt-Mehta, V, Donn SM.
  Neonatal Drug Formulary. In:  Donn SM (ed).  The Michigan Manual of Guide to Neonatal Intensive Care.  Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

• Bhatt-Mehta, V, Donn SM.
  Effects of maternal drug administration on the Fetus and the Newborn. In:  Donn SM (ed).  The Michigan Manual of Guide to Neonatal Intensive Care.  Futura Publishing Co., Mt. Kisco, NY, 1996, 2003.

• Bhatt-Mehta, V, Schumcaher RE.
  Criteria for Drug Use Evaluation, Surfactants. Volume 4, 1994.  Publication of the American Society of Hospital Pharmacists.

• Bhatt-Mehta, V
  Prescription Drugs for Children.  A Consumer Guide. International Publications, Lincolnwood, Chicago, IL. 1997.

• Bhatt-Mehta, V
  Pediatric Critical Care In: Lake K et al. (eds) Pharmacotherapy Self-Assessment Program - Pediatrics Module.  American College of Clinical Pharmacy, Kansas City, MO January, 2000.

• Bhatt-Mehta, V
  Introduction to Neonatology  In: Nahata MC, Caballero, S (eds) Pediatric Pharmacotherapy,  American College of Clinical Pharmacy, Lenexa, KS (under review) June 2011.

• Bhatt-Mehta V, Donn SM.           
  Pharmacologic agents. In Donn SM, Sinha SK (Eds.). Manual of Neonatal Respiratory
  Care, 3rd edition. New York, Springer Science+ Business Media, LLC 2012.

• Bhatt-Mehta V. Introduction to neonatology. In: Benavides S, Nahata MC, eds. Pediatric Pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy, ISBN: 978-1-932658-89-7; 2012; 850 pages; paperback.
• Bhatt-Mehta V, Donn SM. Pharmacologic agents. In Donn SM, Sinha SK (Eds.). Manual of Neonatal Respiratory Care, 3rd edition. New York, Springer Science 2012.

Invited Editorials

• Bhatt-Mehta V.  Should parents use cough and cold preparations for their children?  Ann Pharmacother 2004; 38:1964-66.
• Bhatt-Mehta, V, Donn SM. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia. Expert Rev. Clin. Pharmacol. Early online, 1–3 (2014)

Letters to Editor

• Bhatt-Mehta V, Barks J, Schumacher RE. Letter to the editor (P3). Pediatrics December 2006. (Ref article: Early prophylaxis of adrenal insufficiency to prevent Bronchopulmonary dysplasia; a multicenter trial. (Watterberg K et al. Pediatrics 2004; 114: 1649-1657)
• Bhatt-Mehta V, Ng CM, Schumacher RE. The authors reply.

(Ref article: Allegaert K, van den Anker JN: Neonatal Abstinence Syndrome: On the Evidence to Add Breastfeeding to Any Clinical Pathway. Pediatr Crit Care Med 2014; 15:579–580)

Book Reviews

• Bhatt-Mehta, V.
  Ed: Gerald G Briggs BPharm FCCP, Roger K Freeman MD, and SumnerJ Yaffe MD.  Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 8th Edition Ann Pharmacother 2009; 43:154-155.

• Bhatt-Mehta, V.
  Eds: Richardson, M, Chant, C, Cheeseman KH, Finks SW, Hemstreet BA, Hume AL, et al. Pharmacotherapy Self-Assessment Program, 7th ed. Book 4. Pediatrics.  Ann Pharmacother  Published Online, 8 Mar 2011, theannals.com DOI 10.1345/aph.1P694.

• Bhatt-Mehta, V.
  Ed: Gerald G Briggs B.Pharm FCCP, Roger K Freeman MD, and Sumner J Yaffe MD.  Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 9th Edition Ann Pharmacother 2011…..

Opinion/White Papers
 
1.  ACCP PEDIATRICS PRN OPINION PAPER

Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group
Bhatt-Mehta, V, Buck ML, Chung, AM, Farrington, EA, Hagmann, TM, Hoff, DS, LaRochelle JM, Pettit, RS, Phan, HP, Potts, AL, Smith, KP, Parrish, RH, II.  Pharmacotherapy 2013; 33: 243–251.

2.  Recommendations for Meeting the Pediatric Patient's Need for a Clinical Pharmacist: A Joint Opinion of the Pediatrics Practice and Research Network of the American College of Clinical Pharmacy and the Pediatric Pharmacy Advocacy Group.
Bhatt-Mehta, V, Buck ML, Chung, AM, Farrington, EA, Hagmann, TM, Hoff, DS, LaRochelle J M, Pettit, RS, Phan, HP, Potts, AL, Smith, KP, Parrish, RH, II. Pediatr Pharmacol Ther  2012 Jul-Sep; 17(3): 281–291.

SCIENTIFIC ABSTRACTS (Presented at National and International Conferences)

• Bhatt V.  In-vitro comparison of three different infusion systems.  Thesis presentation.  University of Cincinnati College of Pharmacy, July 1987.
• Bhatt V. Clinical pharmacology of dopamine and dobutamine in newborn infants.  Research Conference, Children's Hospital Research Foundation, Columbus, Ohio, September 1987.
• Bhatt V.  Determination of dopamine in plasma using a specific HPLC method.  Ninth Annual Children's Hospital and Children's Hospital Research Foundation Research Forum, Columbus, Ohio, June 1988.
• Bhatt V, Patterson A.  In-vitro comparison of three different infusion systems.  Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 1988, Dallas, Texas.
• Bhatt V, Nahata MC.  In-vitro stability of dopamine and theophylline, tolazoline, and dobutamine. Annual Meeting of the American Society of Hospital Pharmacists,Nashville, TN, June, 1989.
• Bhatt V, Nahata MC. Pharmacokinetics of Dopamine in critically ill newborn infants.  Annual Meeting of the American College of Clinical Pharmacy, Kansas City, Kansas, August, 1989.
• Bhatt-Mehta V, Johnson CE, Schumacher RE.  Pharmacokinetics of gentamicin in neonates on extracorporeal membrane oxygenation.  Second International Conference of the Extracorporeal Life Support Organization, Ann Arbor, Michigan, November 1990.
• Bhatt-Mehta V, Kapai S.  Vancomycin serum concentration utilization evaluation in neonates. Mid-year Clinical Meeting of the American Society of Hospital Pharmacists, December 1990, Las Vegas, Nevada.
• Jacobson PA, Johnson CJ, Bhatt-Mehta V.  Ceftriaxone drug use evaluation in pediatric patients. Mid-year Clinical Meeting of the American Society of hospital Pharmacists, December 1990, Las Vegas, Nevada.
• Bhatt-Mehta V, Johnson CE, Schumacher RE.  Pharmacokinetics of gentamicin in neonates on ECMO.  Midyear Clinical Meeting of the American Society of hospital Pharmacists, December 1990, Las Vegas, Nevada.
• Bhatt-Mehta V, Rosen D. Pharmacodynamic effects of oral Midazolam in infants and children.  Annual meeting of the American College of Clinical Pharmacy, Minneapolis, MN, August 1991.
• Bhatt-Mehta V, Deluga KS. Chronic renal failure in a neonate due to in-utero exposure to Lisinopril.  Annual Meeting of the American College of Clinical Pharmacy, Minneapolis, MN, August 1991.
• Bhatt-Mehta V, King R, Rosen DA, Maksym C, Whitmore R.  Physical ompatability and chemical stability of Midazolam with various total parenteral nutrition solutions.  Mid-year Clinical Meeting of the American Society of Hospital Pharmcists.  December 1991, New Orleans, Louisiana.
• Rosen DA, Bhatt-Mehta V, Rosen KR. Oral sedation of Infants and children in the Intensive Care Unit: A pharmacokinetic and pharmacodynamic study.  International Anaethesia Society Annual Meeting, San Francisco, CA. March 1992.
• Rosen DA, Rosen KR, Bhatt-Mehta V. Alfentanil and propofol for bone marrow procedures: A dose-response study. American Academy of Pediatrics, Spring Session, April 1992.
• Rosen KR, Rosen DA, Callow L, Bove EL, Reynolds PI, Shayevitz JR, Malviya SV, Wilton SVT, Lupinetti FM, Bhatt-Mehta V. Caudal epidural morphine for the control of postoperative pain in children undergoing cardiac surgery.  American Academy of pediatrics, spring Session, April 1992.
• Bhatt-Mehta V, Paglia R. Physical compatibility and chemical stability of propofol in parenteral nutrition solutions.  Mid-year Clinical meeting of the American Society of Hospital Pharmacists, December 1992, Orlando FL.
• Bhatt-Mehta V, Johnson CJ, Thiesen V, Donn SM.  Accuracy and reliability of dosing equations to individualize theophylline treatment in the apnea of prematurity.  Annual meeting of the American College of Clinical Pharmacy. August, 1993, Reno Sparks, Nevada.
• Klarr JM, Faix RG, Pryce CJ, Bhatt-Mehta V.  Randomized blinded trial of dopamine versus dobutamine for hypotension in preterm infants with RDS.  1993 Annual Meeting of the American Academy of Pediatrics, Perinatal Pediatrics Section.
• Agarwal M, Leninger N, Bhatt-Mehta V, Johnson CE.  Stability and Compatibility of Fentanyl Citrate and Midazolam Hydrochloride during Intravenous Co-administration.  Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 1993, Atlanta, Georgia.
• Mancari SC, McKown J, Johnson CE, Bhatt-Mehta V.  Stability and Compatibility of Morphine Sulfate and Midazolam Hydrochloride During Intravenous Co-administration.  Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December, 1993.  Atlanta, Georgia.
• Reed S, Bhatt-Mehta V, Johnson CE, Donn SM.  Prospective evaluation of two dosing equations of theophylline in apnea of prematurity.  Mid-year clinical meeting of the American Society of Hospital Pharmacists. December 1994.  Orlando, Florida.
• Behm D, Bhatt-Mehta V, Taylor R.  Long term use of neuromuscular blockers in a Pediatric intensive care Unit:Observational study.  Mid-year Clinical Meeting of the American Society of Hospital Pharmacists.  December 1994, Orlando, Florida.
• Bhatt-Mehta V, Jones C.  Pediatric critical care guide for Pediatric Pharmacists.  Third Annual pediatric Technology Conference. September 1994, Napa, CA.
• Bhatt-Mehta V, Donn SM, Schork MA, Reed S, Johnson CE.  Prospective evaluation of two dosing equations for dosing theophylline in premature infants.  Annual meeting of the American College of Clinical Pharmacy.  Washington D.C., August 1995.
• Nelson M, Bhatt-Mehta V, Schumacher RE, Becker M.  Comparison of two methods of surfactant administration and the effect on dosing-associated hypoxemia.  Annual meeting of the American College of Clinical Pharmacy, Washington D.C., August 1995 AND Society for Pediatric Research regional meeting, September-October 1995.
• Bhatt-Mehta V, Behm D, Taylor R.  Use of non-depolarizing neuromuscular blocking agents in a Pediatric Intensive Care Unit:  An observational study.  4 th Annual Pediatric Technology Conference of the Pharmacy Advocacy Group, Newport, RI, October 1995.
• Bhatt-Mehta V, Wright E, Dwyer S.  Implementation of an Intravenous Electrolyte Administration Policy at a Pediatric Teaching Institution.  4 th annual Pediatric Technology Conference of the Pediatric Pharmacy Advocacy Group. Newport, RI.  October 1995.
• Wong G, Brown L, Bhatt-Mehta V.  Stability and compatibility of Ketamine HCL and Midazolam HCL during y-site co-infusion.  Midyear Clinical meeting of the American Society of Health-System Pharmacists.  Las Vegas, NV.  December 1995.
• Michaels A, Hirata S, Bhatt-Mehta V. Stability and compatibility of Atracurium Besylate and Midazolam HCL during y-site co-infusion.  Midyear clinical meeting of the American Society of health-System Pharmacists.  Las Vegas, NV.  December 1995.
• Bhatt-Mehta V, Jones C.  Sedation in the neonatal intensive care unit: Lorazepam or Midazolam?  ACCP Winter Forum.  Monterey, CA.  February 1996.
• Bhatt-Mehta V, Schumacher RE, Faix RG.  Gentamicin Pharmacokinetics in neonates on ECMO:  A prospective controlled study.  ACCP Winter Forum.  Monterey CA.  February 1996.
• Bhatt-Mehta V, Hamby C, Donn SM.  Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory ventilation.  A Case-matched study.  5th Annual Pediatric Technology Conference of the Pediatric Pharmacy Advocacy group.  Scottsdale, AZ.  September, 1996.
• Bhatt-Mehta V, Hamby C, Donn SM.  Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory   ventilation.  A Case-matched study. American College of Clinical Pharmacy Spring Practice and Research Forum.  Panama City, FL.  April 1997.
• Bhatt-Mehta V, Schumacher RE, Faix RG, Stirrup M, Brenner T.  Vancomycin Nephrotoxicity in newborn infants: A case-control retrospective study.  Annual Meeting of the American College of Clinical Pharmacy. November, 1997.
• Bhatt-Mehta V, Kapila S.  An observational study evaluating the use of milrinone lactate in pediatric cardiothoracic postoperative patients.   American College of Clinical Pharmacy Spring Practice and Research Forum. Palm Springs, CA.  April, 1998.
• Bhatt-Mehta V, Schumacher RE, Faix RG, Stirrup M, Brenner T.  Vancomycin Nephrotoxicity in newborn infants: A case-control retrospective study. Midwestern Society for Pediatric Research,   Chicago, IL September 1998.
• Bhatt-Mehta V, Kapila S.  An observational study evaluating the use of milrinone lactate in pediatric cardiothoracic postoperative patients.7th Annual Pediatric Pharmacy Advocacy Group Conference, Kiawah Islands, SC.  October, 1998.
• Bhatt-Mehta V, Moler F, Zahrra J, Custer J.  Cisatracurium infusion in infants 0-2 years in a pediatric intensive care unit: An open label study.  Society of Critical Care Medicine 28th educational and scientific symposium.  San Francisco, CA.  January 1999.
• Bhatt-Mehta V, Moler F, Zahrra J, Custer J.  Cis-atracurium infusion in infants 0-2 years in a pediatric intensive care unit: An open label study. International Congress on Clinical Pharmacy. American College of Clinical Pharmacy, Orlando, FL. April 1999.
• Juzysta N, Bhatt-Mehta V. An observational study evaluating thrombocytopenia due to amrinone lactate in pediatric cardiothoracic postoperative patients. Midyear clinical meeting of the American Society of Health-System Pharmacists. Orlando, FL. December 1999.
• Odetola F, Bhatt-Mehta V, Moler F, Zahrra J, Custer J.  Pharmacokinetics of Cisatracurium in infants 0-2 years in a pediatric intensive care unit: An open label study. Society of Critical Care Medicine 29th educational and scientific symposium.   Orlando, Florida, February 2000.
• Bhatt-Mehta V, Jujzsta N.  Comparison of thrombocytopenia due to amrinone and milrinone on pediatric postoperative cardiac surgery patients.  Third World Congress on Pediatric Intensive Care. Montreal, Canada.  June 2000.
• Chapman R, Fiore, T, Bhatt-Mehta, V, Pearlman, M, Faix, R.  Maternal and    Transplacental Pharmacokinetics of Cefazolin for Intrapartum Prophylaxis of Group B Streptococcal In fection in Penicillin-allergic women.  2001 Pediatric Academic Societies Meeting, Baltimore, MD. April 2001.
• Streetman DD, VandenBussche HL, Price J, Bhatt-Mehta, V.  Evaluation of amphotericin B deoxycholate and lipid-based amphotericin B in pediatric oncology patients. ASHP Mid-year Clinical Meeting, Las Vegas, NV. December 2000.
• Bhatt-Mehta V, Hamby C, Donn SM.  Gentamicin Pharmacokinetics in neonates receiving high frequency oscillatory ventilation.  A Case-matched study. Society of Critical Care Medicine 31st Educational and Scientific Symposium.   San Diago, CA. January 2002.
• Phan H, Bhatt-Mehta V, Bratton SL.  Compliance with a sedation algorithm accompanied by Physician Standing orders for Ventilated Patients in the Pediatric Intensive Care Unit. ASHP Midyear Clinical Meeting, December 2002, Atlanta, GA.
• Bhatt-Mehta V, Lamar K, Streetman DD, Schumacher RE. Correlation of Serum and Salivary Caffeine Concentrations in premature Infants.  32nd Critical Care Congress, Society of Critical Care Medicine, San Antonio, TX January 2003.
• Bhatt-Mehta V, Annich G, Custer JR.  Effects of extracorporeal membrane   oxygenation circuit on Lorazepam. ACCP Spring and Research Forum, Palm Springs CA April 2003.
• Baker C, Schumacher RE, Barks J, Vazquez D, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension. Pediatric Academic Societies’ 2005 Annual Meeting. Washington DC. May 2005.
• Baker C, Schumacher RE, Barks J, Vazquez D, Bhatt-Mehta, V. Evaluation of Hydrocortisone in neonates with pressor resistant hypotension. (Encore) American College of Clinical Pharmacy, San Francisco, CA. October 2005.
• Bhatt Mehta,V, Williams P, Vazquez D, Barks J. Monte Carlo Simulations for optimized population pharmacokinetic study design of hydrocortisone in neonate. University of Michigan 3M Schools of Pharmacy, Medicine and Public Health collaboration poster dinner. March 2006.
• Bhatt Mehta,V, Williams P, Vazquez D, Barks J. Monte Carlo Simulations for optimized population pharmacokinetic study design of hydrocortisone in neonate. ACCP Spring and Research Forum, Monterey, CA April 2006.
• Bhatt-Mehta,V, Neal C Jr, Vazquez D. Effect of early life Glucocorticoid administration on the Limbic-Hypothalamic-Pituitary-adrenal axis stress response. Pediatric Academic Societies’ 2005 Annual Meeting. San Francisco, CA. April-May 2006.
• VanLooy JW, Tran P, Schumacher RE, Bhatt-Mehta, V.    Evaluation of Premedication Algorithm for Non-Emergent Intubation in a Neonatal Intensive Care Unit.  Pediatric Academic Societies’ 2007 Annual Meeting. Toronto, Canada. May 2007.
• Lattimore K, Vazquez D, Barks J, Bhatt-Mehta, V.  Developmental Outcome of VLBW infants treated with hydrocortisone for refractory hypotension.    Pediatric Academic Societies’ 2005 Annual Meeting. Toronto, Canada. May 2007.
• Bhatt-Mehta, V, Williams PW, Vazquez D, Neal C, Jr, Barks JDE. Population Pharmacokinetics of Hydrocortisone in neonates with Pressor resistant Hypotension. Annual Clinical and Translational Research Conference. Washington DC. March 2008.
• Bhatt-Mehta, V, Williams PW, Vazquez D, Neal C, Jr, Barks JDE. Population Pharmacokinetics of Hydrocortisone in neonates with Pressor resistant Hypotension. Annual Conference of the Pediatric Academic Societies. Honolulu, HI. May 2008.
• Mohammad A Attar, Bhatt-Mehta, V, Hieber S, Schumacher, RE. Would Prophylactic PDA Treatment Decrease Hospital Resources Utilization? Midwestern Society for Pediatric Research Annual Meeting, Cleveland OH, October 2008.
• Smith PB, Capparelli EV, Castro, LM, Valencia G, Bidegain M, Schelonka R, Finer N,  van den Anker J, MacKendrick W, Arrieta A, Ward R, Bhatt-Mehta, V, Cohen-Wolkowiez M, Wade KC, Blumer JL, Hope W, Kearns GL, Benjamin DK Jr. on behalf of the Meropenem Study Team. Pediatric Academic Societies Annual Meeting, Baltimore, MD May 2009. Pharmacokinetics and Safety of Meropenem in Young Infants with Intra-Abdominal Infections. A multicenter trial- preliminary results. Pediatric Academic Societies Annual Meeting, Baltimore, MD May 2009.
• Bhatt-Mehta V, Williams PJ, Vazquez DM, Barks JS. Population Pharmacokinetics of Intravenous Hydrocortisone in Newborn Infants (final results). Pediatric Academic Societies Annual Meeting. Baltimore, MD, May 2009.
• Bhatt-Mehta V, Barks JD. Free vs Total Cortisol Levels in Treatment of Adrenal Insufficiency in the Newborn. Presented at the third International Conference of the American College of Clinical Pharmacy and European Society of Clinical Pharmacy, Orlando, FL. April   2009.
• Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates. Pediatric Academic Societies Annual Meeting. Vancouver, BC May 2010.
• Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates. American College of Clinical Pharmacy Spring Research Forum, Charlotte, NC, April 2010.
• Smith PB, Capparelli EV, Castro, LM, Valencia G, Bidegain M, Schelonka R, Finer N,  van den Anker J, MacKendrick W, Arrieta A, Ward R, Bhatt-Mehta, V, Cohen-Wolkowiez M, Wade KC, Blumer JL, Hope W, Kearns GL, Benjamin DK Jr. on behalf of the Meropenem Study Team.Pharmacokinetics and Safety of Meropenem in Young Infants with Intra-Abdominal Infections. Multicenter trial-Final Results. Pediatric Academic Societies Annual Meeting. Vancouver, BC May 2010.
• Attar MA, Schumacher RE, Wojtecki J, Hieber S, Bhatt-Mehta, V. Improving practice of prophylactic treatment of patent ductus arteriosus in premature neonates.
• Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 2010.
• Edwin, S, Nielson, J, Bhatt-Mehta, V, Dorch, M, Alaniz, C. Therapeutic anticoagulation with enoxaparin in Obese Patients. Society of Critical Care Medicine 40th Educational and Scientific Symposium, San Diego, CA, January 2011.
• Bhatt-Mehta, V, Wagner, C, Christensen, M, Barks JD. Reliability and Validity of the sedation subscale of the modified Neonatal, Pain, Agitation and Sedation scale. Pediatric Academic Societies Annual Meeting. Denver, CO, May 2011.
• Bhatt-Mehta, V, Schumacher, RE. Patterns of use of intravenous caffeine in a Neonatal Intensive care Unit. European Society for Pediatric Research Annual meeting, Newcastle, UK. October 2011.
• Bhatt-Mehta, V, Wagner, C, Christensen, M, Barks JD. Reliability and Validity of the sedation subscale of the modified neonatal, Pain, Agitation and Sedation scale. European Society for Pediatric Research Annual meeting, Newcastle, UK. October 2011.
• Schumacher RE, Ng CM, Bhatt-Mehta V.  Success of a methadone treatment protocol for neonatal drug withdrawal following in-utero drug exposure to substances of abuse. European Society for Pediatric Research Annual Meeting, Istanbul, Turkey. October 2012.
• Schumacher RE, Ng CM, Bhatt-Mehta V.  Success of a methadone treatment protocol for neonatal drug withdrawal following in-utero drug exposure to substances of abuse. American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October 2012.
• Sarkar SS, Bhatt-Mehta V, Sarkar S. Does Maternal Intrapartum Antibiotic Treatment Prolong the Incubation Time Required for Blood Cultures to Become Positive for Infants with Early-Onset Sepsis? Pediatric Academic Societies Annual Meeting. Washington DC May 2013.
• Bhatt-Mehta,V, Sing,K, Hsu,T, Dungarani, R, Dechert, R, Schumacher,RE, Sarkar, S. Incidence of Bronchopulmonary Dysplasia Following Administration of Prophylactic Surfactant for Neonatal Respiratory Distress Syndrome.  Pediatric Research Symposium, Department of Pediatrics, University of Michigan. Ann Arbor, MI October 2013.
• Bhatt-Mehta, V, Sing, K, Hsu, T, Dungarani, R, Dechert, R, Schumacher, RE,  Sarkar, S. Incidence of Bronchopulmonary Dysplasia Following Administration of Prophylactic Surfactant for Neonatal Respiratory Distress Syndrome  Mid-year Clinical Meeting of the American Society of Hospital Pharmacists. December 2013.

Graduate Theses

• In-vitro comparison of three different medication infusion systems.  Pharm. D. thesis, University of Cincinnati, 1986. 
• Phytochemical investigations of Sapindus trifoliatus Linn. M.S. (Pharmacy) thesis, Gujerat University, India, 1979.